塞拉尼斯(CE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CE 塞拉尼斯

交易中 01-13 13:31:32 EST

45.47

-0.17

-0.37%

最高46.81	最低44.70	成交量77.68万
今开46.24	昨收45.64	日振幅4.62%
总市值49.79亿	流通市值49.51亿	总股本1.10亿
成交额3,549万	换手率0.71%	流通股本1.09亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CE","market":"US","secType":"STK","nameCN":"塞拉尼斯","latestPrice":45.47,"timestamp":1768329089124,"preClose":45.64,"halted":0,"volume":776809,"delay":0,"floatShares":108876831,"shares":109504894,"eps":-28.222372,"marketStatus":"交易中","change":-0.17,"latestTime":"01-13 13:31:32 EST","open":46.24,"high":46.81,"low":44.7,"amount":35493184.679854,"amplitude":0.046231,"askPrice":45.5,"askSize":100,"bidPrice":45.43,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-28.222372,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1768338000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1106283600000,"exchange":"NYSE","adjPreClose":45.64,"dividendRate":0.002639,"preHourTrading":{"tag":"盘前","latestPrice":46.37,"preClose":45.64,"latestTime":"09:20 EST","volume":305,"amount":14051.29754,"timestamp":1768314021785},"postHourTrading":{"tag":"盘后","latestPrice":45.92,"preClose":45.64,"latestTime":"18:45 EST","volume":58539,"amount":2672198.7876,"timestamp":1768261538499},"volumeRatio":0.538344,"impliedVol":0.6843,"impliedVolPercentile":0.7291},"requestUrl":"/m/hq/s/CE","defaultTab":"news","newsList":[{"id":"2601593339","title":"港股异动 | 时代天使(06699)涨超5% 获TüV南德隐矫产品欧盟MDR-CE证书 推进高标准海外市场准入","url":"https://stock-news.laohu8.com/highlight/detail?id=2601593339","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601593339?lang=zh_cn&edition=full","pubTime":"2026-01-08 10:48","pubTimestamp":1767840515,"startTime":"0","endTime":"0","summary":"消息面上，据时代天使官网消息，近日，时代天使在上海举办MDR-CE证书授证仪式。此次获得国际权威欧盟公告机构的认可，标志着时代天使隐形矫治相关产品在安全性、有效性及合规性方面全面符合欧盟医疗器械法规要求，也意味着时代天使在高标准海外市场准入上迈出重要一步。获得MDR-CE证书代表时代天使产品完全满足欧盟对医疗器械安全性、有效性及全生命周期合规性的强制性法律要求，具有极高的国际认可度与市场公信力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390218.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["FESXmain","BK4585","BK4588","BK1593","BK1100","BK4109","CE","BK1583","FSXEmain","BK1587","06699"],"gpt_icon":0},{"id":"2595202395","title":"港股异动 | 启明医疗-B(02500)盘中涨超7% Cardiovalve系统正式递交欧洲CE MDR认证申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2595202395","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595202395?lang=zh_cn&edition=full","pubTime":"2025-12-29 14:40","pubTimestamp":1766990426,"startTime":"0","endTime":"0","summary":"消息面上，启明医疗近期宣布，Cardiovalve经导管三尖瓣置换系统已正式向欧洲公告机构递交CE认证的全部申请资料，标志着该产品在欧洲市场的准入进程迈出关键一步。此次Cardiovalve系统正式步入CE认证阶段，意味着启明医疗在“四瓣一体”的产品战略布局上更进一步，在已成熟的主瓣、肺瓣产品线基础上，进一步完善了三尖瓣治疗矩阵。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386437.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1100","CE","BK4588","BK1574","02500","BK4109","BK4585"],"gpt_icon":0},{"id":"2595827429","title":"健世科技-B(09877)：JensClip已递交CE认证注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2595827429","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595827429?lang=zh_cn&edition=full","pubTime":"2025-12-29 07:41","pubTimestamp":1766965296,"startTime":"0","endTime":"0","summary":"JensClip是一款为治疗重度二尖瓣反流而设计的创新医疗器械，器械操作简便可靠。JensClip的创新设计已在全球进行了专利布局。目前，JensClip在中国已完成国家药品监督管理局注册申请递交并且获得受理，一年期随访结果优异，正处于注册审评阶段。JensClip亦已顺利在海外开展临床应用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386297.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CE","BK4588","BK4585","09877","BK1100","BK4109"],"gpt_icon":0},{"id":"2593428823","title":"港股异动 | 启明医疗-B(02500)涨超4% 三尖瓣置换产品Cardiovalve正式递交欧盟CE认证申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2593428823","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593428823?lang=zh_cn&edition=full","pubTime":"2025-12-24 10:34","pubTimestamp":1766543684,"startTime":"0","endTime":"0","summary":"消息面上，启明医疗发布公告称，于近日，集团已就Cardiovalve经导管三尖瓣置换系统正式向欧洲公告机构递交CE MDR认证的全部申请资料。Cardiovalve系统是一款同时可用于治疗二尖瓣反流和三尖瓣反流的经导管介入置换产品。与同类产品相比，Cardiovalve系统经股静脉的入路方式显著提升了治疗安全性，产品最大55mm的大瓣环设计适用约95%的患者群体，同时，其独特的短瓣架设计可有效降低心室流出道梗阻风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385310.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02500","CE","BK4109","BK4588","BK1574","FESXmain","FSXEmain","BK1100","BK4585","BK1583"],"gpt_icon":0},{"id":"2593449822","title":"启明医疗-B(02500)：Cardiovalve经导管三尖瓣置换系统递交CE MDR认证申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2593449822","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593449822?lang=zh_cn&edition=full","pubTime":"2025-12-24 07:10","pubTimestamp":1766531426,"startTime":"0","endTime":"0","summary":"智通财经APP讯，启明医疗-B(02500)发布公告，于近日，集团已就Cardiovalve经导管三尖瓣置换系统(Cardiovalve系统)正式向欧洲公告机构递交CE MDR认证的全部申请资料。Cardiovalve系统是一款同时可用于治疗二尖瓣反流和三尖瓣反流的经导管介入置换产品。与同类产品相比，Cardiovalve系统经股静脉的入路方式显著提升了治疗安全性，产品最大55mm的大瓣环设计适用约95%的患者群体，同时，其独特的短瓣架设计可有效降低心室流出道梗阻风险。Cardiovalve系统操作简单、安全、可复制性强，只需定位、锚定、释放三个步骤完成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385227.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02500","BK4585","BK4588","BK1100","BK1574","CE","BK4109","BK1583"],"gpt_icon":0},{"id":"2592198827","title":"凯投宏观：若美国AI泡沫破裂，亚洲新兴市场恐难幸免","url":"https://stock-news.laohu8.com/highlight/detail?id=2592198827","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592198827?lang=zh_cn&edition=full","pubTime":"2025-12-19 22:25","pubTimestamp":1766154329,"startTime":"0","endTime":"0","summary":"金吾财讯 | 凯投宏观(Capital Economics)在一份报告中称，新兴市场股票的AI泡沫尚未破裂，且明年可能进一步膨胀。市场经济学家Elias Hilmer称：“虽然今年新兴市场股票的估值普遍上涨，但仍普遍低于美国。“他补充称，新兴市场与美国AI股票之间的巨大估值差距预计明年不会大幅收窄。然而，如果该AI泡沫像凯投宏观(CE)预测的那样在2027年破裂，较低的新兴市场估值不太可能提供太多缓冲。在这种情况下，台湾和韩国将面临大幅回调。他称，如果在该泡沫破裂后全球市场出现持续回调，不断上升的风险溢价将对亚洲以科技股为主的新兴市场构成压力。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210625/YzM0ZmE0OGYyYmI1ZTk0YjVmZmU4ZTU4MTIzMDA2MDU4MDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YzM0ZmE0OGYyYmI1ZTk0YjVmZmU4ZTU4MTIzMDA2MDU4MDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"295581","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4109","BK4585","CE","BK4588"],"gpt_icon":0},{"id":"1159858803","title":"塞拉尼斯公司更新资本结构 以延长债务到期时间","url":"https://stock-news.laohu8.com/highlight/detail?id=1159858803","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159858803?lang=zh_cn&edition=full","pubTime":"2025-12-18 05:43","pubTimestamp":1766007834,"startTime":"0","endTime":"0","summary":"塞拉尼斯公司更新资本结构，以延长债务到期时间","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4109","CE","BK4585","BK4588"],"gpt_icon":0},{"id":"2592696778","title":"诺唯赞(688105.SH)六项呼吸道病原体核酸检测试剂盒取得欧盟CE IVDR认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2592696778","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592696778?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:13","pubTimestamp":1765959238,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺唯赞(688105.SH)公告，公司六项呼吸道病原体核酸检测试剂盒于近日取得欧盟CE IVDR认证，可在欧盟国家和认可欧盟CE认证的国家进行销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382546.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4109","FESXmain","CE","BK4585","FSXEmain","688105","BK0216"],"gpt_icon":0},{"id":"1115680698","title":"塞拉尼斯公布2027年到期6.665%高级票据和2028年到期6.850%高级票据的提前结果和增大投标规模","url":"https://stock-news.laohu8.com/highlight/detail?id=1115680698","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115680698?lang=zh_cn&edition=full","pubTime":"2025-12-16 21:31","pubTimestamp":1765891875,"startTime":"0","endTime":"0","summary":"塞拉尼斯公布2027年到期6.665%高级票据和2028年到期6.850%高级票据的提前结果和增大投标规模","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CE","BK4585","BK4588","BK4109"],"gpt_icon":0},{"id":"2590488592","title":"圣湘生物(688289.SH)：全自动核酸处理系统(S-S13E-P/S-S13E-P1)获得欧盟CE认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2590488592","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590488592?lang=zh_cn&edition=full","pubTime":"2025-12-11 18:36","pubTimestamp":1765449376,"startTime":"0","endTime":"0","summary":"智通财经APP讯，圣湘生物 发布公告，公司的产品全自动核酸处理系统于近日获得欧盟CEIVDR认证。该款仪器本次获得欧盟CEIVDR认证，标志着公司在分子诊断技术国际化与标准化进程迈出关键一步。这一里程碑不仅体现了产品的卓越性能与安全标准，更展现了公司引领行业创新、服务全球市场的坚定承诺。未来，公司将持续推动技术革新与方案融合，赋能全球医疗机构与公共卫生体系，助力构建更高效、精准、可靠的健康防控新生态。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380496.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["FSXEmain","BK4588","FESXmain","BK0239","BK4109","688289","CE","BK4585"],"gpt_icon":0},{"id":"1135214949","title":"塞拉尼斯宣布现金收购要约，最高1,000,000,000美元，用于支付2027年到期的6.665%高级票据及2028年到期的6.850%高级票据","url":"https://stock-news.laohu8.com/highlight/detail?id=1135214949","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135214949?lang=zh_cn&edition=full","pubTime":"2025-12-02 21:13","pubTimestamp":1764681192,"startTime":"0","endTime":"0","summary":"塞拉尼斯宣布现金收购要约，最高1,000,000,000美元，用于支付2027年到期的6.665%高级票据及2028年到期的6.850%高级票据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4109","BK4585","CE","BK4588"],"gpt_icon":0},{"id":"2586277243","title":"亚辉龙(688575.SH)取得IVDR CE认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2586277243","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586277243?lang=zh_cn&edition=full","pubTime":"2025-11-27 17:07","pubTimestamp":1764234449,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亚辉龙(688575.SH)发布公告，公司于近日收到了由BSI Group The Netherlands B.V.签发的IVDR CE最高风险等级Class D认证证书，产品名称：iFlash-HIV Combo人类免疫缺陷病毒抗原和抗体检测试剂盒(化学发光法)，用于定性检测人血清或血浆中的 HIV p24 抗原和HIV-1/HIV-2抗体，辅助诊断HIV感染和用于献血筛查。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374492.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4109","BK4588","BK4585","CE","688575","BK0239"],"gpt_icon":0},{"id":"2584183185","title":"普门科技(688389.SH)获多项产品获IVDR CE认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2584183185","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584183185?lang=zh_cn&edition=full","pubTime":"2025-11-20 15:41","pubTimestamp":1763624500,"startTime":"0","endTime":"0","summary":"智通财经APP讯，普门科技(688389.SH)公告，公司的26项电化学发光试剂产品以及血红蛋白层析柱获得欧盟公告机构TÜV南德意志集团签发的IVDR CE认证。新的欧盟体外诊断医疗器械法规（IVDR，EU2017/746）替代原欧盟体外诊断医疗器械指令（IVDD，98/79/EC）对欧盟市场的体外诊断医疗器械进行管理。截至目前，公司已有累计53项电化学发光试剂产品获得IVDR CE认证。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1371525.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4109","BK0251","BK4588","CE","688389"],"gpt_icon":0},{"id":"1125440243","title":"塞拉尼斯第三季度调整后每股收益为1.34美元，超出IBES预期的1.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1125440243","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125440243?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:00","pubTimestamp":1763571620,"startTime":"0","endTime":"0","summary":"11月6日 - 塞拉尼斯第三季度净收益为-13.53亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4109","CE"],"gpt_icon":0},{"id":"1162523185","title":"异动解读 | 塞拉尼斯盘中大涨12.50%，第三季度业绩超预期提振投资者信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1162523185","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162523185?lang=zh_cn&edition=full","pubTime":"2025-11-07 22:54","pubTimestamp":1762527264,"startTime":"0","endTime":"0","summary":"特种化学品生产商塞拉尼斯今日盘中大涨12.50%，延续了此前的强劲涨势。这一显著涨幅主要源于公司近期发布的第三季度财报超出市场预期，提振了投资者信心。根据塞拉尼斯公布的财报显示，公司第三季度调整后每股收益达到1.34美元，显著超过分析师预期的1.22美元。除了强劲的季度业绩外，塞拉尼斯的前景展望也进一步提振了投资者信心。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CE"],"gpt_icon":0},{"id":"2581874048","title":"塞拉尼斯盘中异动 早盘股价大涨10.05%报39.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581874048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581874048?lang=zh_cn&edition=full","pubTime":"2025-11-07 22:32","pubTimestamp":1762525939,"startTime":"0","endTime":"0","summary":"北京时间2025年11月07日22时32分，塞拉尼斯股票出现异动，股价快速上涨10.05%。截至发稿，该股报39.74美元/股，成交量2.6727万股，换手率0.02%，振幅1.78%。塞拉尼斯股票所在的化工制品行业中，整体涨幅为0.00%。其相关个股中，亨斯曼材料、塞拉尼斯、Ascent Industries Co.涨幅较大，Asp Isotopes Inc.、亨斯曼材料、海湾资源较为活跃，换手率分别为0.27%、0.22%、0.20%，振幅较大的相关个股有亨斯曼材料、Advansix Inc.、海湾资源，振幅分别为9.16%、7.22%、4.30%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107223219a6e8fbe7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107223219a6e8fbe7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","BK4109","CE"],"gpt_icon":0},{"id":"1100466891","title":"异动解读 | 塞拉尼斯盘前大涨6.62%，第三季度业绩超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1100466891","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100466891?lang=zh_cn&edition=full","pubTime":"2025-11-07 19:28","pubTimestamp":1762514914,"startTime":"0","endTime":"0","summary":"特种化学品生产商塞拉尼斯今日盘前大涨6.62%，延续了周五夜盘7.98%的涨势。这一显著涨幅主要源于公司近期发布的第三季度财报超出市场预期。根据塞拉尼斯公布的财报显示，公司第三季度调整后每股收益达到1.34美元，显著超过分析师预期的1.22美元。塞拉尼斯能够在充满挑战的市场环境中实现超预期的调整后收益，反映了公司在成本控制和运营效率方面的出色表现。除了强劲的季度业绩外，塞拉尼斯的前景展望也提振了投资者信心。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CE"],"gpt_icon":0},{"id":"1161658528","title":"异动解读 | 塞拉尼斯盘前大涨6.62%，第三季度业绩超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1161658528","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161658528?lang=zh_cn&edition=full","pubTime":"2025-11-07 19:28","pubTimestamp":1762514913,"startTime":"0","endTime":"0","summary":"特种化学品生产商塞拉尼斯今日盘前大涨6.62%，延续了周五夜盘的强劲涨势。这一显著涨幅主要源于公司近期发布的第三季度财报超出市场预期。根据塞拉尼斯公布的财报显示，公司第三季度调整后每股收益达到1.34美元，显著超过分析师预期的1.22美元。此外，塞拉尼斯表示，受益于成本和库存削减以及营运资金时间安排的优化，公司仍有望在2025年产生7亿至8亿美元的自由现金流。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CE"],"gpt_icon":0},{"id":"2581300518","title":"圣湘生物(688289.SH)产品取得医疗器械注册证及欧盟CE认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2581300518","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581300518?lang=zh_cn&edition=full","pubTime":"2025-11-07 18:06","pubTimestamp":1762510000,"startTime":"0","endTime":"0","summary":"智通财经APP讯，圣湘生物 发布公告，公司于近日获得三项产品认证及注册，其中两项为国家三类医疗器械注册证，一项为欧盟CEIVDR认证。本次EB病毒检测试剂获得欧盟CEIVDR认证，进一步丰富了公司疱疹病毒检测产品线，亦标志着公司在产品质量、技术性能及管理体系上全面符合国际严格标准，是公司分子诊断战略和国际化战略的重要成果之一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1366703.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688289","BK0239","BK1100","159883","09996","BK1222","CE","BK1583","FESXmain","BK4109","09997","BK1574","BK4588","BK4585","FSXEmain"],"gpt_icon":0},{"id":"1199735916","title":"异动解读 | 塞拉尼斯夜盘大涨7.98%，第三季度业绩超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1199735916","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199735916?lang=zh_cn&edition=full","pubTime":"2025-11-07 16:58","pubTimestamp":1762505934,"startTime":"0","endTime":"0","summary":"周五夜盘，特种化学品生产商塞拉尼斯股价大幅上涨7.98%，引发市场广泛关注。根据塞拉尼斯公布的财报显示，公司第三季度调整后每股收益达到1.34美元，显著超过分析师预期的1.22美元。塞拉尼斯能够在充满挑战的市场环境中实现超预期的调整后收益，反映了公司在成本控制和运营效率方面的出色表现。公司表示，受益于成本和库存削减以及营运资金时间安排的优化，塞拉尼斯仍有望在2025年产生7亿至8亿美元的自由现金流。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.celanese.com","stockEarnings":[{"period":"1week","weight":0.0719},{"period":"1month","weight":0.0492},{"period":"3month","weight":0.1181},{"period":"6month","weight":-0.1982},{"period":"1year","weight":-0.298},{"period":"ytd","weight":0.0795}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0497},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.0194}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"塞拉尼斯公司的历史起源于1918年。目前的塞拉尼斯于2004年根据特拉华州法律注册成立。该公司是一家全球性的化学和特种材料公司。该公司是用于各种高价值应用的高性能工程聚合物的全球领先生产商，也是世界上最大的乙酰产品生产商之一，乙酰产品是几乎所有主要行业的中间化学品。公司广泛的产品组合服务于多种终端用途，包括汽车、化学添加剂、建筑、消费和工业胶粘剂、医疗、消费电子产品、储能、过滤、油漆和涂料、造纸和包装、工业应用和纺织品。","yearOnYearQuotes":[{"month":1,"riseRate":0.52381,"avgChangeRate":-0.011836},{"month":2,"riseRate":0.52381,"avgChangeRate":-0.008442},{"month":3,"riseRate":0.619048,"avgChangeRate":0.040293},{"month":4,"riseRate":0.761905,"avgChangeRate":0.062719},{"month":5,"riseRate":0.52381,"avgChangeRate":0.010444},{"month":6,"riseRate":0.52381,"avgChangeRate":-0.01033},{"month":7,"riseRate":0.619048,"avgChangeRate":0.023251},{"month":8,"riseRate":0.47619,"avgChangeRate":-0.019584},{"month":9,"riseRate":0.380952,"avgChangeRate":-0.02522},{"month":10,"riseRate":0.714286,"avgChangeRate":0.021128},{"month":11,"riseRate":0.714286,"avgChangeRate":0.018078},{"month":12,"riseRate":0.52381,"avgChangeRate":0.028577}],"exchange":"NYSE","name":"塞拉尼斯","nameEN":"Celanese"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"塞拉尼斯(CE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供塞拉尼斯(CE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"塞拉尼斯,CE,塞拉尼斯股票,塞拉尼斯股票老虎,塞拉尼斯股票老虎国际,塞拉尼斯行情,塞拉尼斯股票行情,塞拉尼斯股价,塞拉尼斯股市,塞拉尼斯股票价格,塞拉尼斯股票交易,塞拉尼斯股票购买,塞拉尼斯股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"塞拉尼斯(CE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供塞拉尼斯(CE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}